Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. Potential Risksof Relying on Open-AccessAIModels…

AI Risks February 10, 2025 · Pharmaceutical Executive

Potential Risksof Relying on Open-AccessAIModels - Pharmaceutical Executive

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI identifies therisksassociated …

Read the original at Pharmaceutical Executive ↗

Topics
Healthcare
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”

Related articles

  • Driving Field Excellence withAI-Enhanced Rep Support - Pharmaceutical Executive AI Hallucinations · Dec 18, 2024
  • The Leap Forward: Practical Gains for PharmaAIUse - Pharmaceutical Executive AI Risks · Nov 14, 2024
  • How AI is Changing the Drug Development Journey - Pharmaceutical Executive AI Risks · Feb 22, 2024
  • Preventing Bias in AI: Q&A with Michael Armstrong - Pharmaceutical Executive AI Hallucinations · Jun 21, 2024
  • Avicenna.AI Receives EU Certification for AI Imaging Products - Pharmaceutical Executive AI Use Cases · Jul 08, 2024
  • The Future of Digital Twins: Q&A with Rudy Kuhn - Pharmaceutical Executive AI Use Cases · Jul 25, 2024

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact